The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding MS. We also aim to understand how these differ in the ability to conduct outcomes research using the available data.
In our initial research, we are attempting to answer the following question:
What is the impact of the journal articles related to the specific registries?
*Impact was calculated based on citation impact analysis for each identified article (for the last 10 years).
MSbase is a global registry based in Australian with 73 countries involved.
The European Register for Multiple Sclerosis (EUReMS) is a cross-border multiple sclerosis (MS) data collection in Europe.
This is a summary of the top ten most frequent journals
We are currently in process to add data for additional registries regarding MS and will amend the blog-post as they become available.
Learn more about “Where is the best quality real world data set in Europe“ by clicking on the tag below.